1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Coagulation Analyzers Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Coagulation Analyzers by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Coagulation Analyzers by Country/Region, 2020, 2024 & 2031
2.2 Coagulation Analyzers Segment by Type
2.2.1 Prothrombin Time Testing
2.2.2 Fibrinogen Testing
2.2.3 Activated Clotting Time Testing
2.2.4 D-Dimer Testing
2.2.5 Platelet Function Tests
2.2.6 Anti-Factor Xa Tests
2.2.7 Heparin & Protamine Dose Response Tests for Activated clotting time (ACT)
2.2.8 Other Coagulation Tests
2.3 Coagulation Analyzers Sales by Type
2.3.1 Global Coagulation Analyzers Sales Market Share by Type (2020-2025)
2.3.2 Global Coagulation Analyzers Revenue and Market Share by Type (2020-2025)
2.3.3 Global Coagulation Analyzers Sale Price by Type (2020-2025)
2.4 Coagulation Analyzers Segment by Application
2.4.1 Clinical Laboratories
2.4.2 Point-of-Care Testing
2.4.3 Others
2.5 Coagulation Analyzers Sales by Application
2.5.1 Global Coagulation Analyzers Sale Market Share by Application (2020-2025)
2.5.2 Global Coagulation Analyzers Revenue and Market Share by Application (2020-2025)
2.5.3 Global Coagulation Analyzers Sale Price by Application (2020-2025)
3 Global Coagulation Analyzers by Company
3.1 Global Coagulation Analyzers Breakdown Data by Company
3.1.1 Global Coagulation Analyzers Annual Sales by Company (2020-2025)
3.1.2 Global Coagulation Analyzers Sales Market Share by Company (2020-2025)
3.2 Global Coagulation Analyzers Annual Revenue by Company (2020-2025)
3.2.1 Global Coagulation Analyzers Revenue by Company (2020-2025)
3.2.2 Global Coagulation Analyzers Revenue Market Share by Company (2020-2025)
3.3 Global Coagulation Analyzers Sale Price by Company
3.4 Key Manufacturers Coagulation Analyzers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Coagulation Analyzers Product Location Distribution
3.4.2 Players Coagulation Analyzers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Coagulation Analyzers by Geographic Region
4.1 World Historic Coagulation Analyzers Market Size by Geographic Region (2020-2025)
4.1.1 Global Coagulation Analyzers Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Coagulation Analyzers Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Coagulation Analyzers Market Size by Country/Region (2020-2025)
4.2.1 Global Coagulation Analyzers Annual Sales by Country/Region (2020-2025)
4.2.2 Global Coagulation Analyzers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Coagulation Analyzers Sales Growth
4.4 APAC Coagulation Analyzers Sales Growth
4.5 Europe Coagulation Analyzers Sales Growth
4.6 Middle East & Africa Coagulation Analyzers Sales Growth
5 Americas
5.1 Americas Coagulation Analyzers Sales by Country
5.1.1 Americas Coagulation Analyzers Sales by Country (2020-2025)
5.1.2 Americas Coagulation Analyzers Revenue by Country (2020-2025)
5.2 Americas Coagulation Analyzers Sales by Type
5.3 Americas Coagulation Analyzers Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Coagulation Analyzers Sales by Region
6.1.1 APAC Coagulation Analyzers Sales by Region (2020-2025)
6.1.2 APAC Coagulation Analyzers Revenue by Region (2020-2025)
6.2 APAC Coagulation Analyzers Sales by Type
6.3 APAC Coagulation Analyzers Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Coagulation Analyzers by Country
7.1.1 Europe Coagulation Analyzers Sales by Country (2020-2025)
7.1.2 Europe Coagulation Analyzers Revenue by Country (2020-2025)
7.2 Europe Coagulation Analyzers Sales by Type
7.3 Europe Coagulation Analyzers Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Coagulation Analyzers by Country
8.1.1 Middle East & Africa Coagulation Analyzers Sales by Country (2020-2025)
8.1.2 Middle East & Africa Coagulation Analyzers Revenue by Country (2020-2025)
8.2 Middle East & Africa Coagulation Analyzers Sales by Type
8.3 Middle East & Africa Coagulation Analyzers Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coagulation Analyzers
10.3 Manufacturing Process Analysis of Coagulation Analyzers
10.4 Industry Chain Structure of Coagulation Analyzers
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Coagulation Analyzers Distributors
11.3 Coagulation Analyzers Customer
12 World Forecast Review for Coagulation Analyzers by Geographic Region
12.1 Global Coagulation Analyzers Market Size Forecast by Region
12.1.1 Global Coagulation Analyzers Forecast by Region (2026-2031)
12.1.2 Global Coagulation Analyzers Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Coagulation Analyzers Forecast by Type
12.7 Global Coagulation Analyzers Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Coagulation Analyzers Product Portfolios and Specifications
13.1.3 Abbott Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Nihon Kohden
13.2.1 Nihon Kohden Company Information
13.2.2 Nihon Kohden Coagulation Analyzers Product Portfolios and Specifications
13.2.3 Nihon Kohden Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Nihon Kohden Main Business Overview
13.2.5 Nihon Kohden Latest Developments
13.3 Roche Diagnostics
13.3.1 Roche Diagnostics Company Information
13.3.2 Roche Diagnostics Coagulation Analyzers Product Portfolios and Specifications
13.3.3 Roche Diagnostics Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roche Diagnostics Main Business Overview
13.3.5 Roche Diagnostics Latest Developments
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Information
13.4.2 Siemens Healthcare Coagulation Analyzers Product Portfolios and Specifications
13.4.3 Siemens Healthcare Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Siemens Healthcare Main Business Overview
13.4.5 Siemens Healthcare Latest Developments
13.5 Sysmex
13.5.1 Sysmex Company Information
13.5.2 Sysmex Coagulation Analyzers Product Portfolios and Specifications
13.5.3 Sysmex Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sysmex Main Business Overview
13.5.5 Sysmex Latest Developments
13.6 Thermo Fisher Scientific
13.6.1 Thermo Fisher Scientific Company Information
13.6.2 Thermo Fisher Scientific Coagulation Analyzers Product Portfolios and Specifications
13.6.3 Thermo Fisher Scientific Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Thermo Fisher Scientific Main Business Overview
13.6.5 Thermo Fisher Scientific Latest Developments
13.7 Diagnostica Stago Sas
13.7.1 Diagnostica Stago Sas Company Information
13.7.2 Diagnostica Stago Sas Coagulation Analyzers Product Portfolios and Specifications
13.7.3 Diagnostica Stago Sas Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Diagnostica Stago Sas Main Business Overview
13.7.5 Diagnostica Stago Sas Latest Developments
13.8 Helena Laboratories
13.8.1 Helena Laboratories Company Information
13.8.2 Helena Laboratories Coagulation Analyzers Product Portfolios and Specifications
13.8.3 Helena Laboratories Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Helena Laboratories Main Business Overview
13.8.5 Helena Laboratories Latest Developments
13.9 Instrumentation Laboratory (Werfen)
13.9.1 Instrumentation Laboratory (Werfen) Company Information
13.9.2 Instrumentation Laboratory (Werfen) Coagulation Analyzers Product Portfolios and Specifications
13.9.3 Instrumentation Laboratory (Werfen) Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Instrumentation Laboratory (Werfen) Main Business Overview
13.9.5 Instrumentation Laboratory (Werfen) Latest Developments
13.10 International Technidyne (ITC)
13.10.1 International Technidyne (ITC) Company Information
13.10.2 International Technidyne (ITC) Coagulation Analyzers Product Portfolios and Specifications
13.10.3 International Technidyne (ITC) Coagulation Analyzers Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 International Technidyne (ITC) Main Business Overview
13.10.5 International Technidyne (ITC) Latest Developments
14 Research Findings and Conclusion
※参考情報 凝固分析装置は、血液の凝固特性を測定するための機器であり、凝固系の異常を評価するために不可欠な役割を果たしています。凝固系は、出血を防ぎ、傷が治癒する際に重要なプロセスであり、これに関与する多くの因子やメカニズムがあります。凝固分析装置は、これらのプロセスを理解し、診断、治療、モニタリングを行うために使用されます。 この装置の主な機能は、血液凝固の速度や程度を定量的に評価することです。例えば、PT(プロトロンビン時間)やAPTT(活性化部分トロンボプラスチン時間)などの検査を通じて得られるデータは、抗凝固療法を受けている患者や出血の危険性がある患者にとって非常に重要です。 凝固分析装置の特徴は、主にその測定原理、精度、操作の容易性、結果の迅速性に集約されます。一般的な凝固分析装置は、血液サンプルを投入し、凝固因子の反応を観察するためのセンサーやレーザー等の技術を使用して、リアルタイムでの測定が可能です。また、結果は数分以内に得られるため、臨床現場での迅速な判断をサポートします。 装置は様々な種類があり、大きく分けると手動装置と自動装置があります。手動装置は、検査員が試薬を手で加え、反応を観察するタイプであり、主に研究目的や小規模な医院で使用されます。一方、自動装置は、サンプルの自動投入、洗浄、測定を一貫して行うことができるため、大規模な病院や検査センターで広く利用されています。 さらに、近年では、ポイント・オブ・ケア(POC)装置と呼ばれる小型で携帯可能な装置も登場しています。これにより、病院の外でも迅速に凝固検査を行うことができ、特に緊急医療や外科手術などの現場では、その利便性が重視されています。 用途としては、主に血液凝固機能の評価、抗凝固療法のモニタリング、血液疾患の診断、手術前の出血リスクの評価などがあります。凝固検査は、心血管疾患や血栓症、出血性疾患のリスク評価にも活用されており、患者の治療方針や投薬調整に多大な影響を与えています。このように、凝固分析装置は、直接的に患者の生命にかかわる重要な検査機器であると言えます。 関連技術としては、凝固因子の測定や、他の生命科学技術と組み合わせた高度な解析技術が挙げられます。たとえば、分子生物学的手法や免疫測定法と組み合わせることで、より詳細かつ正確な凝固因子の情報を得ることができます。これにより、凝固異常の診断精度が向上し、より効果的な医療が提供できるようになります。 凝固分析装置は、今後も技術革新が続く分野であり、より高精度、迅速な測定が求められています。また、AI(人工知能)やデータ解析技術の進展により、患者個々のリスク評価や治療方針の提案がさらに高度化することが期待されています。このように、凝固分析装置の発展は、臨床医療の質を向上させる重要な要素であり、未来の医療においてもその重要性は増していくことでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/